Batch Release Transformation Lessons From a Large Biopharma Disposition Owner

Oct 14, 2026 | Michael Edwards

At a recent gathering of European quality leaders, one of Veeva’s customers — a senior director and Qualified Person (QP) at a European multinational biopharma company — shared his experience of transitioning to digital-first batch release workflows.

Optimizing batch disposition processes means maintaining market compliance while embracing remote release capabilities and the latest digital applications. But to achieve streamlined and confident release decisions, biopharma quality leaders are navigating an uncertain regulatory landscape and reimagining data and processes.

The lessons from the QP are valuable for any quality leader looking to embrace digital and remote batch release. Modernizing batch release requires careful focus on both internal process change and external regulatory dialog, but clear benefits await those organizations that make the transition.

Paper is painful — but the path to digital isn’t always clear

In Europe, the batch release process outlined in EudraLex Volume 4, Annex 16 appears simple enough:

1. Batch documentation is reviewed by the disposition team
2. A certificate is issued and registered
3. The batch is released to the market or sponsor

But during the discussion, the QP revealed a typical challenge of legacy batch release processes: separate sites for drug products, packaging, and API manufacturing interact during the batch production journey, making the final release process “tedious” and “cumbersome” when executed manually on paper.

Reviewing paper documents from multiple CMOs, combining them, and piecing together the batch genealogy step by step continues to demand high levels of time and effort from QPs and disposition owners. And because paper batch certificates and registers remain prevalent, the process has to be completed on-site using wet signatures and stamps.

As the organization looked to replace its legacy processes with modernized and digital batch release, it met several hurdles.

No clear regulatory guidance

BioPhorum’s 2026 Batch Disposition Manifesto shows that there is industry-wide appetite for digital transformation, but for now regulators simply haven’t kept pace.

The EMA released a four-page Q&A consultation document about “remote” batch certification back in 2022, but there are still no formal EU guidelines for digital batch certification generally.

Whether digital batch certification is allowed at all depends on an organization’s national competent authority, so European biopharmas aiming to digitize batch release may struggle to know where to start.

The picture is similar in the U.S. In the absence of a standalone remote batch release guidance document from the FDA, batch disposition guidance comes solely from the electronic records and signatures requirements of 21 CFR Part 11, and the quality control unit framework in 21 CFR Part 211.

Batch data and processes are parallel transformations

For a fully digital process, the entire batch lifecycle should be available in a remotely accessible digital format. However, it takes concerted effort to digitize discrete sets of analog batch data from multiple contract manufacturing organizations (CMOs) and sites.

And full batch release modernization isn’t just about converting paper to electronic records. To achieve the full efficiency benefits of optimized batch release, quality leaders will need to systematically reimagine and reshape key processes — which means careful planning, gap analysis, and batch release solution scoping.

Three success factors for batch release transformation

For these reasons, industry leaders are taking a phased approach to batch release transformation. The QP recommends three key actions.

1. Dialog with your local authority

In the absence of EU-wide regulation, the QP’s organization made direct contact with its local competent GMP authority to discuss its batch release digitization plans, and secure awareness, alignment, and buy-in from the beginning of the project.

Dialog is actively continuing, with batch release process enhancements shared with the authority as they are developed for examination and feedback.

2. Prioritize batch registers and e-signatures

The QP makes a distinction between “digitization” and “digitalization” of batch release. Where digitization involves simply scanning paper documents to preserve them, and still require a QP to be on-site, comprehensive digitalization involves the application of electronic batch registers and legally binding, eIDAS-compliant e-signatures to facilitate remote batch release.

These digitalization ingredients should form the primary targets of a batch release modernization project.

3. Full digital transformation as the end goal

Although remote batch release with electronic batch registers and e-signatures is preferable to on-site paper processes, industry leaders view batch release transformation more holistically, and are moving even further to embed fully optimized and efficient batch processes.

For the QP and his organization, the final stage of full digital transformation is centralizing all batch activity in a purpose-built application. Electronic batch registers and e-signatures are maintained inside the application, but this comprehensive process change focuses on full data integration, optimizing the user experience, and leveraging automation.

Once this happens, batch data and genealogy will be integrated with the rest of the quality ecosystem, processes connected for maximum efficiency and throughput, and real-time interface with ERP, MES, and LIMS platforms becomes possible.

Reaping the benefits of modern batch release

For the quality leaders building active dialog with their regulatory authorities and reaching the third stage of digital transformation with an application like Veeva Batch Release, the operational benefits are clear and measurable.

Instead of manually collating paper records, disposition owners and QPs view batch histories and lot genealogies that are automatically assembled from real-time QMS, ERP, RIM, and LIMS content and data flows.

Market ship decisions become faster, simpler, and more flexible, with remote digital certificate of analysis (CoA) and compliance (CoC) issuance that’s free from the on-site demands of analog processes.

And varying national requirements no longer pose a barrier for disposition, with jurisdictional control functionality providing automatic market-by-market compliance assessment.

Organizations benefit from reduced risk, carrying costs, and deferred revenue by maximizing speed, efficiency, and throughput.

Moving to modern batch release

Learn how Veeva Batch Release transforms release processes by watching the video: Optimizing Batch Release with Veeva.